Detalhe da pesquisa
1.
Cardiometabolic risk factors and antithrombotic treatment in a Mexican population with atrial fibrillation and heart failure with reduced ejection fraction.
Gac Med Mex
; 159(1): 24-31, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36930551
2.
[Characterisation of thromboembolic risk in a mexican population with non-valvular atrial fibrillation and its effect on anticoagulation (MAYA Study)]. / Caracterización del riesgo tromboembólico en una población mexicana con fibrilación auricular (FA) no-valvular y su efecto en la indicación de anticoagulación (estudio MAYA).
Gac Med Mex
; 152(4): 473-8, 2016.
Artigo
em Espanhol
| MEDLINE | ID: mdl-27595250
3.
Gender differences and management of stroke risk of nonvalvular atrial fibrillation in an upper middle-income country: Insights from the CARMEN-AF registry.
Int J Cardiol Heart Vasc
; 22: 117-122, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30705937
4.
Factores de riesgo cardiometabólico y tratamiento antitrombótico en población mexicana con fibrilación auricular e insuficiencia cardiaca con fracción de expulsión reducida / Cardiometabolic risk factors and antithrombotic treatment in a Mexican population with atrial fibrillation and heart failure with reduced ejection fraction
Gac. méd. Méx
; 159(1): 24-31, ene.-feb. 2023. tab, graf
Artigo
em Espanhol
|
LILACS-Express
| ID: biblio-1448261